Literature DB >> 18448695

Occult hepatitis C virus infection revisited with ultrasensitive real-time PCR assay.

Philippe Halfon1, Marc Bourlière, Denis Ouzan, Damien Sène, David Saadoun, Hacène Khiri, Guillaume Pénaranda, Agnes Martineau, Valérie Oulès, Patrice Cacoub.   

Abstract

Occult hepatitis C infection is regarded as a new entity that should be considered when diagnosing patients with a liver disease of unknown origin. Using an ultrasensitive real-time PCR assay, we demonstrated that occult hepatitis C virus (HCV) infection cannot be found in peripheral blood mononuclear cells of patients with cryptogenic liver diseases, HCV--associated systemic vasculitis, or connective tissue diseases. The significance of such occult infection must be elucidated.

Entities:  

Mesh：

Substances：

Year:  2008        PMID： 18448695      PMCID： PMC2446830          DOI： 10.1128/JCM.00345-08

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN： 0095-1137            Impact factor:   5.948


  17 in total

1.  Prevalence of transmitted transfusion virus (TTV) in populations at different risk for hepatitis virus: hemodialysis, chronic hepatitis C and cryptogenetic hepatitis patients.

Authors:  P Halfon; M Bourliere; J M Feryn; H Khiri; M Chanas; J M Salvadori; D Ouzan
Journal:  J Hepatol       Date:  1999-03       Impact factor: 25.083

2.  Surreptitious hepatitis C virus (HCV) infection detected in the majority of patients with cryptogenic chronic hepatitis and negative HCV antibody tests.

Authors:  W N Schmidt; P Wu; J Cederna; F A Mitros; D R LaBrecque; J T Stapleton
Journal:  J Infect Dis       Date:  1997-07       Impact factor: 5.226

3.  Detection of hepatitis C virus (HCV) in serum and peripheral-blood mononuclear cells from HCV-monoinfected and HIV/HCV-coinfected persons.

Authors:  Jason T Blackard; Laura Smeaton; Yoichi Hiasa; Norio Horiike; Morikazu Onji; Denise J Jamieson; Irma Rodriguez; Kenneth H Mayer; Raymond T Chung
Journal:  J Infect Dis       Date:  2005-06-07       Impact factor: 5.226

4.  Cryptogenic chronic liver disease and serum or liver hepatitis B virus markers. Their possible correlations and etiologic significance.

Authors:  G Diodati; P Pontisso; P Bonetti; D Stenico; F Noventa; A Alberti; G Realdi
Journal:  Digestion       Date:  1988       Impact factor: 3.216

5.  Hepatitis C virus replicates in peripheral blood mononuclear cells of patients with occult hepatitis C virus infection.

Authors:  I Castillo; E Rodríguez-Iñigo; J Bartolomé; S de Lucas; N Ortíz-Movilla; J M López-Alcorocho; M Pardo; V Carreño
Journal:  Gut       Date:  2005-05       Impact factor: 23.059

6.  Real-time PCR assays for hepatitis C virus (HCV) RNA quantitation are adequate for clinical management of patients with chronic HCV infection.

Authors:  Philippe Halfon; Marc Bourlière; Guillaume Pénaranda; Hacène Khiri; Denis Ouzan
Journal:  J Clin Microbiol       Date:  2006-07       Impact factor: 5.948

7.  Impact of various handling and storage conditions on quantitative detection of hepatitis C virus RNA.

Authors:  P Halfon; H Khiri; V Gerolami; M Bourliere; J M Feryn; P Reynier; A Gauthier; G Cartouzou
Journal:  J Hepatol       Date:  1996-09       Impact factor: 25.083

8.  HCV core protein localizes in the nuclei of nonparenchymal liver cells from chronically HCV-infected patients.

Authors:  Viviana Falcón; Nelson Acosta-Rivero; Mineko Shibayama; Glay Chinea; Jorge V Gavilondo; María C de la Rosa; Ivón Menéndez; Bienvenido Gra; Santiago Dueñas-Carrera; Ariel Viña; Waldo García; Maritza González-Bravo; Jose Luna-Munoz; Magdalena Miranda-Sanchez; Juan Morales-Grillo; Juan Kouri; Victor Tsutsumi
Journal:  Biochem Biophys Res Commun       Date:  2005-04-22       Impact factor: 3.575

9.  Detection of hepatitis C virus (HCV) RNA in the liver of healthy, anti-HCV antibody-positive, serum HCV RNA-negative patients with normal alanine aminotransferase levels.

Authors:  Vicente Carreño; Margarita Pardo; Juan Manuel López-Alcorocho; Elena Rodríguez-Iñigo; Javier Bartolomé; Inmaculada Castillo
Journal:  J Infect Dis       Date:  2006-05-16       Impact factor: 5.226

10.  Occult hepatitis C virus infection in patients in whom the etiology of persistently abnormal results of liver-function tests is unknown.

Authors:  Inmaculada Castillo; Margarita Pardo; Javier Bartolomé; Nuria Ortiz-Movilla; Elena Rodríguez-Iñigo; Susana de Lucas; Clara Salas; Jose A Jiménez-Heffernan; Arturo Pérez-Mota; Javier Graus; Juan Manuel López-Alcorocho; Vicente Carreño
Journal:  J Infect Dis       Date:  2003-12-31       Impact factor: 5.226
View more
  7 in total

1.  Does occult hepatitis C virus infection exist?

Authors:  Vicente Carreño; Javier Bartolomé; Inmaculada Castillo; Juan Antonio Quiroga
Journal:  J Clin Microbiol       Date:  2008-10       Impact factor: 5.948

2.  Occult hepatitis C virus infection and its relevance in clinical practice.

Authors:  Tram Nq Pham; Tomasz I Michalak
Journal:  J Clin Exp Hepatol       Date:  2012-01-02

3.  Detection of hepatitis C virus (HCV) RNA in the peripheral blood mononuclear cells of HCV-infected patients following sustained virologic response.

Authors:  Mahmoud A Khattab; Yehia Zakaria; Eslam Sadek; Aliaa S Abd El Fatah; Magdy Fouad; Muhammed Khattab; Hend M Moness; Nashwa Mohamed Adel; Elham Ahmed
Journal:  Clin Exp Med       Date:  2022-01-23       Impact factor: 3.984

Review 4.  Occult HCV Infection: The Current State of Knowledge.

Authors:  Mohammad Saeid Rezaee-Zavareh; Reza Hadi; Hamidreza Karimi-Sari; Mohammad Hossein Khosravi; Reza Ajudani; Fardin Dolatimehr; Mahdi Ramezani-Binabaj; Seyyed Mohammad Miri; Seyed Moayed Alavian
Journal:  Iran Red Crescent Med J       Date:  2015-11-29       Impact factor: 0.611

Review 5.  The place of immunotherapy in the management of HCV-induced vasculitis: an update.

Authors:  Laurent Chiche; Stanislas Bataille; Gilles Kaplanski; Noemie Jourde
Journal:  Clin Dev Immunol       Date:  2012-08-15

6.  Prevalence and follow-up of occult HCV infection in an Italian population free of clinically detectable infectious liver disease.

Authors:  Laura De Marco; Paola Manzini; Morena Trevisan; Anna Gillio-Tos; Franca Danielle; Cinzia Balloco; Alessandra Pizzi; Eleonora De Filippo; Sergio D'Antico; Beatrice Violante; Adriano Valfrè; Franco Curti; Franco Merletti; Lorenzo Richiardi
Journal:  PLoS One       Date:  2012-08-22       Impact factor: 3.240

Review 7.  A New Twist to a Chronic HCV Infection: Occult Hepatitis C.

Authors:  Bashar M Attar; David Van Thiel
Journal:  Gastroenterol Res Pract       Date:  2015-06-24       Impact factor: 2.260
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.